Sales License drove TER up 66% from $3 to $5/shareHIKU is probably going to get its Sales License soon, maybe even before Beleave (CSE:BE). Seems like an awesome entry point for investors.
TerraAscend (CSE:TER) (
https://thecse.com/en/listings/life-sciences/terrascend-corp) recieved its Sales License on March 11, 2018 and the stock ran from $3.00 to over $5.00 within a matter of days and volume has increased substantially since recieving its license. Not expecting that kind of movement for HIKU but definitely something to look out for.
Beleave had their sales inspection on Feb 8, 2018 and still no Sales license.
HIKU had their sales inspection on Feb 13, 2018.
HIKU has more positive catalysts in its pipeline than any other company out there. Sales License, MB store openings, Alberta licesnses/stores, Sask licesnses/stores, BC licesnses/stores, Oil license, Production Capacity expansion, Patient growth, Rec sales growth.
I'm pretty bullish on the outlook for HIKU, especially from these levels. Over $4.00/share I would have been a seller, under $2.00/share it is a buy all day long.